BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14509657)

  • 1. Dominant torsinA mutations in cellular systems.
    Baptista MJ; O'Farrell CA; Cookson MR
    Adv Neurol; 2004; 94():73-8. PubMed ID: 14509657
    [No Abstract]   [Full Text] [Related]  

  • 2. TorsinA and early-onset torsion dystonia.
    Bragg DC; Slater DJ; Breakefield XO
    Adv Neurol; 2004; 94():87-93. PubMed ID: 14509659
    [No Abstract]   [Full Text] [Related]  

  • 3. Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors.
    Bragg DC; Camp SM; Kaufman CA; Wilbur JD; Boston H; Schuback DE; Hanson PI; Sena-Esteves M; Breakefield XO
    Neuroscience; 2004; 125(3):651-61. PubMed ID: 15099679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in the molecular biology of DYT1 dystonia.
    Walker RH; Shashidharan P
    Mov Disord; 2003 Oct; 18(10):1102-7. PubMed ID: 14534912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of torsinB.
    O'Farrell C; Lockhart PJ; Lincoln S; De Lucia M; Singleton AB; Dickson DW; Cookson MR
    Brain Res Mol Brain Res; 2004 Aug; 127(1-2):1-9. PubMed ID: 15306116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TorsinA, microtubules and cell polarity.
    Ferrari Toninelli G; Spano P; Memo M
    Funct Neurol; 2003; 18(1):7-10. PubMed ID: 12760408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human torsinA and its dystonia-associated mutant form.
    Liu Z; Zolkiewska A; Zolkiewski M
    Biochem J; 2003 Aug; 374(Pt 1):117-22. PubMed ID: 12780349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular chaperones affect GTP cyclohydrolase I mutations in dopa-responsive dystonia.
    Hwu WL; Lu MY; Hwa KY; Fan SW; Lee YM
    Ann Neurol; 2004 Jun; 55(6):875-8. PubMed ID: 15174023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the porcine TOR1A gene: The first step towards generation of a pig model for dystonia.
    Henriksen C; Madsen LB; Bendixen C; Larsen K
    Gene; 2009 Feb; 430(1-2):105-15. PubMed ID: 19028553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant expression, purification, and comparative characterization of torsinA and its torsion dystonia-associated variant Delta E-torsinA.
    Kustedjo K; Deechongkit S; Kelly JW; Cravatt BF
    Biochemistry; 2003 Dec; 42(51):15333-41. PubMed ID: 14690443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier.
    Kock N; Naismith TV; Boston HE; Ozelius LJ; Corey DP; Breakefield XO; Hanson PI
    Hum Mol Genet; 2006 Apr; 15(8):1355-64. PubMed ID: 16537570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the DYT1 gene in secondary dystonia.
    Bressman SB; de Leon D; Raymond D; Greene PE; Brin MF; Fahn S; Ozelius LJ; Breakefield XO; Kramer PL; Risch NJ
    Adv Neurol; 1998; 78():107-15. PubMed ID: 9750907
    [No Abstract]   [Full Text] [Related]  

  • 13. TorsinA immunoreactivity in inclusion bodies in trinucleotide repeat diseases.
    Walker RH; Good PF; Shashidharan P
    Mov Disord; 2003 Sep; 18(9):1041-4. PubMed ID: 14502672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA.
    Bragg DC; Kaufman CA; Kock N; Breakefield XO
    Mol Cell Neurosci; 2004 Dec; 27(4):417-26. PubMed ID: 15555920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transmission in DYT1 dystonia.
    Augood SJ; Hollingsworth Z; Albers DS; Yang L; Leung J; Breakefield XO; Standaert DG
    Adv Neurol; 2004; 94():53-60. PubMed ID: 14509654
    [No Abstract]   [Full Text] [Related]  

  • 16. TorsinB--perinuclear location and association with torsinA.
    Hewett JW; Kamm C; Boston H; Beauchamp R; Naismith T; Ozelius L; Hanson PI; Breakefield XO; Ramesh V
    J Neurochem; 2004 Jun; 89(5):1186-94. PubMed ID: 15147511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities.
    Grundmann K; Reischmann B; Vanhoutte G; Hübener J; Teismann P; Hauser TK; Bonin M; Wilbertz J; Horn S; Nguyen HP; Kuhn M; Chanarat S; Wolburg H; Van der Linden A; Riess O
    Neurobiol Dis; 2007 Aug; 27(2):190-206. PubMed ID: 17601741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of extrapyramidal diseases].
    Brice A
    Rev Neurol (Paris); 1998 Nov; 154(11):739-42. PubMed ID: 9894286
    [No Abstract]   [Full Text] [Related]  

  • 19. TorsinA protects against oxidative stress in COS-1 and PC12 cells.
    Kuner R; Teismann P; Trutzel A; Naim J; Richter A; Schmidt N; von Ahsen O; Bach A; Ferger B; Schneider A
    Neurosci Lett; 2003 Oct; 350(3):153-6. PubMed ID: 14550917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope.
    Goodchild RE; Kim CE; Dauer WT
    Neuron; 2005 Dec; 48(6):923-32. PubMed ID: 16364897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.